Literature DB >> 10790114

Performance of the ImmunoCard STAT! E. coli O157:H7 test for detection of Escherichia coli O157:H7 in stools.

A Mackenzie1, E Orrbine, L Hyde, M Benoit, F Chan, C Park, J Alverson, A Lembke, D Hoban, W Kennedy.   

Abstract

ImmunoCard STAT! E. coli O157:H7 (Meridian Diagnostics, Inc., Cincinnati, Ohio) is a novel rapid (10-min) test for the presence of Escherichia coli O157:H7 in stools. The test may be performed either directly on stool specimens or on an overnight broth culture of stool. In a multicenter prospective study, 14 of 14 specimens positive by culture for E. coli O157:H7 were positive by the ImmunoCard STAT! O157:H7 test, and there were no false positives from 263 culture-negative specimens. In a retrospective study, the test was positive in 339 (81%) of 417 stored culture-positive specimens and the specificity was 95% (98 of 103 specimens). No false positives were associated with alternate stool pathogens. The ImmunoCard STAT! O157:H7 test has high sensitivity and specificity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10790114      PMCID: PMC86610     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

Review 1.  The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome.

Authors:  P M Griffin; R V Tauxe
Journal:  Epidemiol Rev       Date:  1991       Impact factor: 6.222

2.  Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. Investigators of the Canadian Pediatric Kidney Disease Research Center.

Authors:  P C Rowe; E Orrbine; H Lior; G A Wells; E Yetisir; M Clulow; P N McLaine
Journal:  J Pediatr       Date:  1998-05       Impact factor: 4.406

Review 3.  Consensus conference statement: Escherichia coli O157:H7 infections--an emerging national health crisis, July 11-13, 1994.

Authors: 
Journal:  Gastroenterology       Date:  1995-06       Impact factor: 22.682

4.  Evaluation of the premier EHEC assay for detection of Shiga toxin-producing Escherichia coli.

Authors:  K S Kehl; P Havens; C E Behnke; D W Acheson
Journal:  J Clin Microbiol       Date:  1997-08       Impact factor: 5.948

5.  Hemolytic uremic syndrome in childhood: renal function ten years later.

Authors:  M Van Dyck; W Proesmans; M Depraetere
Journal:  Clin Nephrol       Date:  1988-03       Impact factor: 0.975

6.  Isolation of Shiga-like toxin producing Escherichia coli (O157 and non-O157) in a community hospital.

Authors:  C H Park; K M Gates; N M Vandel; D L Hixon
Journal:  Diagn Microbiol Infect Dis       Date:  1996-10       Impact factor: 2.803

7.  Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Clinical, epidemiologic, and bacteriologic features.

Authors:  C H Pai; R Gordon; H V Sims; L E Bryan
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

8.  Hemolytic-uremic syndrome: an analysis of the natural history and prognostic features.

Authors:  C Loirat; E Sonsino; A Varga Moreno; G Pillion; J C Mercier; F Beaufils; H Mathieu
Journal:  Acta Paediatr Scand       Date:  1984-07

9.  Sensitivities and specificities of premier E. coli O157 and premier EHEC enzyme immunoassays for diagnosis of infection with verotxin (Shiga-like toxin)-producing Escherichia coli. The SYNSORB Pk Study investigators.

Authors:  A M Mackenzie; P Lebel; E Orrbine; P C Rowe; L Hyde; F Chan; W Johnson; P N McLaine
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  Evaluation of a microplate latex agglutination method (Verotox-F assay) for detecting and characterizing verotoxins (Shiga toxins) in Escherichia coli.

Authors:  M A Karmali; M Petric; M Bielaszewska
Journal:  J Clin Microbiol       Date:  1999-02       Impact factor: 5.948

  10 in total
  6 in total

Review 1.  E. coli O157:H7 and other toxigenic strains: the curse of global food distribution.

Authors:  Mary F Bavaro
Journal:  Curr Gastroenterol Rep       Date:  2012-08

2.  Serology and genetics of the flagellar antigen of Escherichia coli O157:H7a,7c.

Authors:  Yuli A Ratiner; Saara Salmenlinna; Marjut Eklund; Markku Keskimäki; Anja Siitonen
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

3.  Comparison of Escherichia coli O157:H7 antigen detection in stool and broth cultures to that in sorbitol-MacConkey agar stool cultures.

Authors:  J R Stapp; S Jelacic; Y L Yea; E J Klein; M Fischer; C R Clausen; X Qin; D L Swerdlow; P I Tarr
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

Review 4.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 5.  Escherichia coli O157: what every internist and gastroenterologist should know.

Authors:  Mary F Bavaro
Journal:  Curr Gastroenterol Rep       Date:  2009-08

Review 6.  Combined Dielectrophoresis and Impedance Systems for Bacteria Analysis in Microfluidic On-Chip Platforms.

Authors:  Cristina Páez-Avilés; Esteve Juanola-Feliu; Jaime Punter-Villagrasa; Beatriz Del Moral Zamora; Antoni Homs-Corbera; Jordi Colomer-Farrarons; Pere Lluís Miribel-Català; Josep Samitier
Journal:  Sensors (Basel)       Date:  2016-09-16       Impact factor: 3.576

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.